Home > Back to Publisher > Report Information

U.S. Osteoporosis Therapeutics Markets

Frost & Sullivan
January 10, 2005
SKU: MC1074062

Abstract Table of Contents Related Reports

Countries covered: United States

Innovative New Products to Stimulate Market Growth

Despite the popularity of bisphosphonates in treating osteoporosis, there is room for improvement in terms of drug efficacy and shorter dosage regimens. Although weekly courses of Fosamax and Actonel have proven effective in managing osteoporosis, strict posture and fasting guidelines coupled with gastrointestinal side effects limit patient compliance. In addition, the market is still in need of more drugs that not only slow the rate of bone loss but also assist in building bone. Such shortcomings in existing treatments are presenting growth opportunities to new market entrants. The introduction of bisphosphonates with monthly and yearly dosing regimens is expected to improve patient compliance, while new anabolic agents are expected to provide severe sufferers with better treatment options.

This Frost & Sullivan research examines the U.S. market for non-hormonal prescription medications used to treat osteoporosis such as bisphosphonates, selective estrogen receptor modulators (SERMs), calcitonins, and parathyroid hormones (PTHs). Each segment provides revenue and patient forecasts by drug, product analysis, and a detailed look at the major issues and factors affecting market growth.

Increased Awareness Essential to Facilitate Diagnosis and Effective Treatment

Low awareness and poor understanding of the disease are a major factor behind the late diagnosis and ineffective treatment for the millions suffering from osteoporosis. The symptoms behind osteoporosis are not easily recognizable until multiple fractures have occurred making it all the more difficult for accurate diagnosis and timely treatment. "Plain X-rays also fail to reveal bone loss until 20 to 50 percent loss has already occurred," observes the analyst of this research. "Consequently, less than 10 percent of the estimated 44 million Americans suffering from osteopenia and osteoporosis are diagnosed and treated." Extensive sales and promotional campaigns should educate patients regarding the importance of receiving treatment at an early stage and equip physicians with the tools necessary to quickly and easily identify the symptoms behind low bone mass.

Anabolic Agents Set to Dramatically Expand Market

Existing antiresorptive therapies are unable to replace lost bone or rebuild new bone mass, and therefore prove ineffective for patients with severe osteoporosis and at a very high risk of developing fractures. "Anabolic agents such as parathyroid hormones (PTHs) are capable of increasing bone mineral density (BMD), restoring skeletal structure, and curtailing fracture risk to a greater extent than traditional drugs used for osteoporosis," explains the analyst.

At present, Eli Lilly’s Forteo (teriparatide), which was launched in December 2002, holds the distinction of being the first and only anabolic agent with the ability to build bone mass. As many other companies follow suit in developing anabolic agents, the osteoporosis therapeutics market is expected to see a surge in revenues.

1. Executive Summary
        1. Executive Summary
                1. Executive Summary

2. Total Market
        1. Overview
                1. Scope and Segmentation
                2. Research Methodology
                3. Introduction
                4. Market and Technology Trends
        2. Market Dynamics
                1. Demand Analysis
                2. Patient Forecasts
                3. Revenue Forecasts
                4. Factors Affecting Market Growth
                5. Industry Issues and Challenges
        3. Compet0itive Landscape
                1. Competitive Structure
                2. Pipeline Analysis
                3. Market Share Analysis
        4. Frost & Sullivan Awards
                1. Product of the Year Award
                2. Industry Innovation and Advancement of the Year Award
                3. Product Innovation Award
                4. Technology Excellence Award
                5. Entrepreneurial Company of the Year

3. Bisphosphonates Market
        1. Overview
                1. Introduction
                2. Market Engineering Analysis
                3. Segment Issues
        2. Market Forecasts and Trends
                1. Revenue Forecasts
                2. Patient Forecasts
                3. Pricing Trends
                4. Product Analysis
        3. Competitive Analysis
                1. Competitive Structure
                2. Market Share Analysis

4. SERMs Market
        1. Overview
                1. Introduction
                2. Market Engineering Analysis
                3. Segment Issues
        2. Market Forecasts and Trends
                1. Revenue Forecasts
                2. Patient Forecasts
                3. Pricing Trends
                4. Product Analysis
        3. Competitive Analysis
                1. Competitive Structure
                2. Market Share Analysis

5. Calcitonins Market
        1. Overview
                1. Introduction
                2. Market Engineering Analysis
                3. Segment Issues
        2. Market Forecasts and Trends
                1. Revenue Forecasts
                2. Patient Forecasts
                3. Pricing Trends
                4. Product Analysis
        3. Competitive Analysis
                1. Competitive Structure
                2. Market Share Analysis

6. Parathyroid Hormones Market
        1. Overview
                1. Introduction
                2. Market Engineering Analysis
                3. Segment Issues
        2. Market Forecasts and Trends
                1. Revenue Forecasts
                2. Patient Forecasts
                3. Pricing Trends
                4. Product Analysis
        3. Competitive Analysis
                1. Competitive Structure
                2. Market Share Analysis

7. Appendix
        1. Decision Support Database
                1. Population 65 and Older
                2. Female Population
                3. Obstetricians and Gynecologists
                4. Medicare Enrollment
                5. Private Health Insurance

More United States Osteoporosis Reports

Opportunities in Bone & Joint Health: Consumer Attitudes & Behaviors by Datamonitor
Introduction The most developed bone and joint health market by far is the US; the total market value in the US exceeded $3 billion in 2008, ...

Kyphoplasty: Driving Growth in the Vertebral Compression Fracture Treatment Market in the US by GlobalData
Kyphoplasty: Driving Growth in the Vertebral Compression Fracture Treatment Market in the US Summary GlobalData viewpoints are an essential source of high quality information on all key ...

U.S. Osteoporosis Market by Frost & Sullivan
This Frost & Sullivan research service titled U.S. Osteoporosis Market provides an overview of osteoporosis and provides market forecasts, along with a complete analysis of ...

U.S. Emerging Osteoporosis Therapeutics Markets by Frost & Sullivan
Lack of Disease Awareness Restrains Industry Growth Many doctors and potential patients remain unaware of the signs of osteoporosis, which is characterized by low bone ...

U.S. Osteoporosis Diagnostics Markets by Frost & Sullivan
New Peripheral Technologies Drive Market Growth As the baby boomer population ages, there will be an increased need to accurately measure the degenerative loss of ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

U.S. Osteoporosis Therapeutics Markets

Share this report

Other tasks

Research Assistance

Related Markets

Osteoporosis Reports

Free Alert Me service